Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors.

[1]  P. Argani,et al.  Pediatric renal cell carcinoma. , 2009, Journal of pediatric urology.

[2]  H. Kijima,et al.  An aggressive course of Xp11 translocation renal cell carcinoma in a 28‐year‐old man , 2009, International journal of urology : official journal of the Japanese Urological Association.

[3]  Y. Ishikawa,et al.  Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry , 2009, Clinical Cancer Research.

[4]  C. Kane,et al.  Renal cell carcinoma in the pediatric population: Results from the California Cancer Registry , 2008, Pediatric blood & cancer.

[5]  Karl J. Dykema,et al.  Renal Translocation Carcinomas: Clinicopathologic, Immunohistochemical, and Gene Expression Profiling Analysis of 31 Cases With a Review of the Literature , 2008, The American journal of surgical pathology.

[6]  P. Argani,et al.  Translocation renal cell carcinoma , 2008, Cancer.

[7]  Ximing J. Yang,et al.  Pediatric renal cell carcinoma as second malignancy: reports of two cases and a review of the literature. , 2007, The Canadian journal of urology.

[8]  M. Ladanyi,et al.  Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum , 2007, The American journal of surgical pathology.

[9]  M. Picken,et al.  Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. , 2007, American journal of clinical pathology.

[10]  S. Tickoo,et al.  Pediatric renal cell carcinoma with oncocytoid features occurring in a child after chemotherapy for cardiac leiomyosarcoma. , 2007, Urology.

[11]  P. Argani,et al.  Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. , 2007, Urology.

[12]  M. Ladanyi,et al.  Translocation carcinomas of the kidney after chemotherapy in childhood. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Ladanyi,et al.  Translocation carcinomas of the kidney. , 2005, Clinics in laboratory medicine.

[14]  L. Bernstein,et al.  A proposed explanation for female predominance in alveolar soft part sarcoma , 2005, Cancer.

[15]  M. Ladanyi,et al.  Renal Carcinomas With the t(6;11)(p21;q12): Clinicopathologic Features and Demonstration of the Specific Alpha-TFEB Gene Fusion by Immunohistochemistry, RT-PCR, and DNA PCR , 2005, The American journal of surgical pathology.

[16]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[17]  Jérôme Couturier,et al.  A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23) , 2003, Oncogene.

[18]  R. Bouvier,et al.  Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2: a cytogenetic and morphologic study. , 2003, Cancer genetics and cytogenetics.

[19]  G. Kovacs,et al.  Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. , 1999, The American journal of surgical pathology.

[20]  H. Saitoh.  Distant metastasis of renal adenocarcinoma , 1981, Cancer.